KODK

Eastman Kodak Company: Q2 2000 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2000, for Eastman Kodak Company, a global leader in imaging and related technologies. The company operates through four primary segments: Consumer Imaging, Kodak Professional, Health Imaging, and Other Imaging. The filing includes unaudited consolidated financial statements and management's discussion of financial condition.

Key Financial Metrics

Cash Flow (YTD 2000): Operating activities used $229 million (compared to $143 million provided in 1999), driven by increases in receivables ($514 million) and inventories ($263 million). Investing activities used $307 million, primarily for capital expenditures. Financing activities provided $427 million, largely from net increases in borrowings.

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 4% in Q2 and 2% YTD compared to 1999. Growth was driven by volume gains in consumer films, papers, and digital cameras, as well as strength in emerging markets (up 13% in Q2). This was partially offset by a $92 million adverse foreign exchange impact in Q2.
• Profitability: Net earnings rose 3% in Q2 and 17% YTD. Operating earnings increased 4% in Q2 and 21% YTD. The YTD improvement is significantly aided by a $44 million reversal of severance costs from the 1999 restructuring program.
• Segment Performance:
  • Consumer Imaging: Sales up 6% (Q2) and 5% (YTD); earnings up 10% (Q2) and 15% (YTD).
  • Kodak Professional: Sales down 10% (Q2) and 9% (YTD) due to reduced sales to the KPG joint venture; earnings down 36% (Q2) and 19% (YTD).
  • Health Imaging: Sales up 4% (Q2) and 2% (YTD); earnings flat (Q2) and up 7% (YTD).
  • Other Imaging: Sales up 8% (Q2) and 3% (YTD); earnings down 25% (Q2) due to acquisition charges, but up 200% (YTD) excluding prior year portfolio charges.
• Acquisitions: Kodak acquired the remaining interest in PictureVision, Inc. for approximately $90 million, recording $25 million in charges for in-process R&D and acquisition costs.

Guidance, Outlook, and Risks

• Restructuring: The 1999 restructuring program is being revised. Approximately 500 fewer employees will be separated than originally planned, reducing expected annual run-rate savings from $170 million to $140 million. A $44 million credit was recorded in Q2 2000 due to these revisions.
• Capital Expenditures: Total capital expenditures are expected to be approximately $1.1 billion for the full year 2000, level with 1999, focusing on manufacturing productivity and digital initiatives.
• Market Risks:
  • Currency: A 10% increase in foreign exchange rates would result in a $54 million loss on forward contracts, though this would be offset by gains on underlying positions.
  • Commodities: A 10% decrease in silver prices would reduce the fair value of silver forward contracts by $21 million, offset by lower manufacturing costs.
  • Interest Rates: A 10% increase in interest rates would decrease the fair value of borrowings by $24 million.
• Unusual Items: Q2 results included a $31 million charge for Eastman Software repositioning and a $15 million charge related to the KPG joint venture cost structure. These were partially offset by a $25 million gain from the de-mutualization of an insurance company.

Investor Verification Checklist

• Verify the sustainability of the $44 million restructuring credit and the revised savings targets of $140 million annually.
• Monitor the performance of the Kodak Professional segment, specifically the impact of the KPG joint venture inventory rebalancing on future sales.
• Assess the integration and profitability timeline for the PictureVision acquisition and the associated $25 million R&D charge.
• Review the trend in working capital, specifically the $514 million increase in receivables and $263 million increase in inventories, and their impact on operating cash flow.
• Confirm the impact of foreign exchange rates on future margins, given the $92 million adverse impact in Q2 2000.